Suboxone and Subutex Questions and Answers
1. What are Suboxone and Subutex?
Suboxone and Subutex are medications approved for the treatment of opiate dependence. Both medicines contain the active ingredient, buprenorphine hydrochloride, which works to reduce the symptoms of opiate dependence.
2. Why did the FDA approve two medications?
Subutex contains only buprenorphine hydrochloride. This formulation was developed as the initial product. The second medication, Suboxone contains an additional ingredient called naloxone to guard against misuse.
Subutex is given during the first few days of treatment, while Suboxone is used during the maintenance phase of treatment.
3. Will most prescriptions be for the Suboxone formulation?
Yes, Suboxone is the formulation used in the majority of patients.
4. How are Suboxone and Subutex different from the current treatment options for opiate dependence such as methadone?
Currently opiate dependence treatments like methadone can be dispensed only in a limited number of clinics that specialize in addiction treatment. There are not enough addiction treatment centers to help all patients seeking treatment. Suboxone and Subutex are the first narcotic drugs available under the Drug Abuse Treatment Act (DATA) of 2000 for the treatment of opiate dependence that can be prescribed in a doctor’s office. This change will provide more patients the opportunity to access treatment.
5. What are some possible side effects of Suboxone and Subutex?
(This is NOT a complete list of side effects reported with Suboxone and Subutex. Refer to the package insert for a more complete list of side effects.)
The most common reported side effect of Suboxone and Subutex include:
* cold or flu-like symptoms
* sleeping difficulties
* mood swings.
Like other opioids Subutex and Suboxone have been associated with respiratory depression (difficulty breathing) especially when combined with other depressants.
6. Are patients able to take home supplies of these medicines?
Yes. Subutex and Suboxone are less tightly controlled than methadone because they have a lower potential for abuse and are less dangerous in an overdose. As patients progress on therapy, their doctor may write a prescription for a take-home supply of the medication.
7. How will FDA know if these drugs are being misused, and what can be done if they are?
FDA has worked with the manufacturer, Reckitt-Benckiser, and other agencies to develop an in-depth risk-management plan. FDA will receive quarterly reports from the comprehensive surveillance program. This should permit early detection of any problems. Regulations can be enacted for tighter control of buprenorphine treatment if it is clear that it is being widely diverted and misused.
8. What are the key components of the risk-management plan?
The main components of the risk-management plan are preventive measures and surveillance.
Preventive Measures include:
* tailored distribution
* Schedule III control under the Controlled Substances Act (CSA)
* child resistant packaging
* supervised dose induction
The risk management plan uses many different surveillance approaches. Some active methods include plans to:
* Conduct interviews with drug abusers entering treatment programs.
* Monitor local drug markets and drug using network areas where these medicines are most likely to be used and possibly abused.
* Examine web sites.
Additionally data collection sources can indicate whether Subutex and/or Suboxone are implicated in abuse or fatalities. These include:
* DAWN—The Drug Abuse Warning Network. This is run by the Substance Abuse and Mental Health Services Administration (SAMHSA) which publishes a collection of data on emergency department episodes related to the use of illegal drugs or non-medical use of a legal drug.
* CEWG—Community Epidemiology Working Group. This working group has agreed to monitor buprenorphine use.
* NIDA—National Institute of Drug Abuse. NIDA will send a letter to their doctors telling them to be aware of the potential for abuse and to report it if necessary.
9. Who can prescribe Subutex and Suboxone?
Only qualified doctors with the necessary DEA (Drug Enforcement Agency) identification number are able to start in-office treatment and provide prescriptions for ongoing medication. CSAT (Center for Substance Abuse Treatment) will maintain a database to help patients locate qualified doctors.
10. How will Subutex and Suboxone be supplied?
Both medications come in 2 mg and 8 mg strengths as sublingual (placed under the tongue to dissolve) tablets.
11. Where can patients get Subutex and Suboxone?
These medications will be available in most commercial pharmacies. Qualified doctors with the necessary DEA identification numbers will be encouraged to help patients locate pharmacies that can fill prescriptions for Subutex and Suboxone.
12.Where can I go for more information?
* Go to: http://www.fda.gov/cder/drug/infopage/subutex_suboxone/default.htm
* Contact the CSAT Buprenorphine Information Center at 866-BUP-CSAT, or via email at email@example.com or http://buprenorphine.samhsa.gov/
Subutex Treatment for Opiate Dependence
Opioid dependency is a medical diagnosis characterized by an individual’s inability to stop using opioids even when objectively it is in his or her best interest to do so. Preoccupation with a desire to obtain and take the drug and persistent drug-seeking behavior is a common characteristic of heroin or other opiate addicts. The DSM-IV-TR clinical guidelines for a definite diagnosis of “dependence” require that three or more of the following six characteristic features be experienced or exhibited:
* A strong desire or sense of compulsion to take the drug;
* Difficulties in controlling drug-taking behavior in terms of its onset, termination, or levels of use;
* A physiological withdrawal state when drug use is stopped or reduced, as evidenced by: the characteristic withdrawal syndrome for the substance; or use of the same (or a closely related) substance with the intention of relieving or avoiding withdrawal symptoms;
* Evidence of tolerance, such that increased doses of the drug are required in order to achieve effects originally produced by lower doses;
* Progressive neglect of alternative pleasures or interests because of drug use, increased amount of time necessary to obtain or take the drug or to recover from its effects;
* Persisting with drug use despite clear evidence of overtly harmful consequences, such as harm to the liver, depressive mood states or impairment of cognitive functioning.
Opiate addition does not discriminate. This insidious addiction affects the lives of every race, sexual identity, and socio-economic class. Opiate addicts suffer an enormous physical craving and mental obsession. It is very hard to truly understand the grips of Opiate dependency due to the physical craving.
Opiate Addiction is tearing families apart, changing good people into hopeless addicts, and creating a problem that is far beyond the typical “drug abuse problem”. Getting help is becoming more difficult. Treatment centers across America are becoming privatized and based on a business model of private pay, thirty day to ninety day stays, in a residential or hospital setting.
Morningside Recovery treats Opiate Addictions in California
Morningside Recovery offers treatment for Opiate addictions and many times also treats chronic pain alcoholism, meth addiction and narcotics addiction.
Opiate addictions treatment at Morningside Recovery has a different approach to treating alcohol, opiate and meth addiction. It’s different because it integrates innovative medical treatment with nutritional support and psychological counseling – all available in a residential setting.
Get the Treatment You Deserve
Located close to San Diego Airport we have had the honor of helping Opiate addicts from the following states:
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming
We assist those who need and want to be discreet or who need a resolution to their Opiate problem. There are daily non-stop flights available.
Copyright ©2008 SubutexHelpline.com All rights reserved. SubutexHelpline.com – Committed to helping those suffering Opiate Addictions.
Suboxone Help | Opiate Addiction Help